Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hing Y Leung

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
British Journal of Nursing (Mark Allen Publishing)|October 10, 2019
The Scottish prostate cryotherapy service-the role of the clinical nurse specialistFiona Birrell, Hing Y Leung
Current Pharmaceutical Design|March 7, 2012
Targeting the EGFR-family for therapy: biological challenges and clinical perspectiveRachana Patel, Hing Y Leung
European Urology|February 20, 2007
Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cellsJoanne Edwards, Hing Y Leung
Clinical Science (London, England : 1979)|August 12, 2009
Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapyAlison K Ramsay, Hing Y Leung
Cancer Letters|August 3, 2021
Evasion of cell death: A contributory factor in prostate cancer development and treatment resistanceKirsteen J Campbell, Hing Y Leung
Current Pharmaceutical Design|March 7, 2012
Approaches for developing novel microtubule targeting agents (MTAs) for therapeutic exploitationAswini Krishnan, James Wilson, Hing Y Leung
Biochimica Et Biophysica Acta|January 26, 2012
Mechanisms of FGFR-mediated carcinogenesisImran Ahmad, Tomoko Iwata, Hing Y Leung
Pharmacological Research|February 22, 2018
Lipid pathway deregulation in advanced prostate cancerLaura Galbraith, Hing Y Leung, Imran Ahmad
Expert Opinion on Drug Discovery|September 16, 2020
Targeting the BAF complex in advanced prostate cancerAndrew Hartley, Hing Y Leung, Imran Ahmad
The Prostate|May 10, 2006
NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cellsKelly Armstrong, Craig N Robson, Hing Y Leung
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
British Journal of Nursing (Mark Allen Publishing)|October 10, 2019
The Scottish prostate cryotherapy service-the role of the clinical nurse specialistFiona Birrell, Hing Y Leung
Current Pharmaceutical Design|March 7, 2012
Targeting the EGFR-family for therapy: biological challenges and clinical perspectiveRachana Patel, Hing Y Leung
European Urology|February 20, 2007
Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cellsJoanne Edwards, Hing Y Leung
Clinical Science (London, England : 1979)|August 12, 2009
Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapyAlison K Ramsay, Hing Y Leung
Cancer Letters|August 3, 2021
Evasion of cell death: A contributory factor in prostate cancer development and treatment resistanceKirsteen J Campbell, Hing Y Leung
Current Pharmaceutical Design|March 7, 2012
Approaches for developing novel microtubule targeting agents (MTAs) for therapeutic exploitationAswini Krishnan, James Wilson, Hing Y Leung
Biochimica Et Biophysica Acta|January 26, 2012
Mechanisms of FGFR-mediated carcinogenesisImran Ahmad, Tomoko Iwata, Hing Y Leung
Pharmacological Research|February 22, 2018
Lipid pathway deregulation in advanced prostate cancerLaura Galbraith, Hing Y Leung, Imran Ahmad
Expert Opinion on Drug Discovery|September 16, 2020
Targeting the BAF complex in advanced prostate cancerAndrew Hartley, Hing Y Leung, Imran Ahmad
The Prostate|May 10, 2006
NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cellsKelly Armstrong, Craig N Robson, Hing Y Leung
Pageof 13